News Releases

Updates every hour. Last Updated: 26-Apr-2025 12:08 ET (26-Apr-2025 16:08 GMT/UTC)

22-Apr-2025

New study reveals mechanism of SUMOylation in regulating DNA damage repair and radiotherapy sensitivity

Hefei Institutes of Physical Science, Chinese Academy of Sciences
Peer-Reviewed Publication

A research team led by Professor ZHAO Guoping at the Hefei Institutes of Physical Science of the Chinese Academy of Sciences, has unveiled a crucial mechanism that helps regulate DNA damage repair, with important implications for improving cancer treatment outcomes. 

Journal

Cell Death and Differentiation

22-Apr-2025

Smart nanotherapy enhances immune attack on melanoma

Hefei Institutes of Physical Science, Chinese Academy of Sciences
Peer-Reviewed Publication

Recently, Prof. WU Zhengyan from the Hefei Institutes of Physical Science of the Chinese Academy of Sciences, in collaboration with Prof. ZHANG Guilong from Binzhou Medical University, has developed an innovative nano-immune agonist that significantly improves immunotherapy outcomes for melanoma—a highly aggressive and hard-to-treat form of skin cancer.

Journal

Journal of Colloid and Interface Science

21-Apr-2025

Stanford Medicine researchers develop RNA blood test to detect cancers, other clues

Stanford Medicine
Peer-Reviewed Publication

Stanford Medicine researchers have created a liquid biopsy test capable of detecting cancers, molecular mechanisms of resistance to treatment and tissue injury.

Journal

Nature

21-Apr-2025

UCLA investigators highlight innovations in prostate and bladder cancer, AI, and patient-centered care at AUA 2025

University of California - Los Angeles Health Sciences
Reports and Proceedings

Investigators from the David Geffen School of Medicine at UCLA and the UCLA Health Jonsson Comprehensive Cancer Center will be involved in more than four dozen sessions at the annual meeting of the American Urological Association April 26 to 29.

21-Apr-2025

AACR: Five MD Anderson researchers honored with 2025 Scientific Achievement Awards

University of Texas M. D. Anderson Cancer Center
Grant and Award Announcement

Five scientists from The University of Texas MD Anderson Cancer Center will be recognized with Scientific Achievement Awards and honors at the American Association for Cancer Research (AACR) Annual Meeting 2025.

Meeting

AACR Annual Meeting 2025

21-Apr-2025

UT Health San Antonio-led discovery means IV medication could be taken orally for range of cancer, Alzheimer’s treatments

University of Texas Health Science Center at San Antonio
Peer-Reviewed Publication

Breakthrough research led by The University of Texas Health Science Center at San Antonio could make any IV drug able to be taken orally for a range of hard-to-treat cancers and other diseases, and redefine how medicines are designed, evaluated and delivered.

Journal

Cell

21-Apr-2025

Michael J. Schell, Ph.D. elected Fellow of the American Statistical Association

H. Lee Moffitt Cancer Center & Research Institute
Grant and Award Announcement

Michael J. Schell, Ph.D., interim chief in the Quantitative Science Division at Moffitt Cancer Center, has been elected a Fellow of the American Statistical Association (ASA), the world’s largest community of statisticians and data scientists. This prestigious honor recognizes his exceptional contributions to statistical sciences and his commitment to advancing the field.

21-Apr-2025

Tumor byproduct blocks immune cells from fighting cancer

University of Chicago Medical Center
Peer-Reviewed Publication

A team of researchers from the University of Chicago, in collaboration with researchers from the University of Pittsburgh, has identified a novel oncometabolite that accumulates in tumors and impairs immune cells’ ability to fight cancer.

Journal

Nature Cell Biology

21-Apr-2025

Penn Medicine at the AACR Annual Meeting 2025

University of Pennsylvania School of Medicine
Reports and Proceedings

Penn researchers will present on the latest advances in cancer science and medicine at the American Association for Cancer Research Annual Meeting.

Meeting

AACR Annual Meeting 2025

21-Apr-2025

Study suggests experimental cancer drug could streamline standard tuberculosis treatment and prevent post-TB lung disease

Johns Hopkins Medicine
Peer-Reviewed Publication

An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, Johns Hopkins Medicine investigators report.

Journal

Nature Communications

Funder

NIH/National Institutes of Health